Form 4: Royalty Pharma Executive Receives Stock Grant
Insider Transaction (Form 4)
Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc, received 11,002 shares of common stock on August 5, 2026.
Summary
- Grant/award: acquired 11,002 Class A Ordinary Shares on August 5, 2026; holds 470,401 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Christopher Hite — Officer (EVP & Chairman, Partnering)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Grant/award | Class A Ordinary Shares | 11,002 | — | — | 470,401 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Grant/award (11,002 shares) |
Keywords
insider transaction, Form 4, RPRX, Royalty Pharma plc, neutral, Christopher Hite
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.